bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
All Web sites
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2014: A M F J
2013: D N O S A J J M A

 
  Other news for:
Cataract
Eye Diseases
Lipoproteins, HDL Cholesterol
 Resources from HONselect
Statins Linked to Raised Risk of Cataracts in Study
But heart benefits of these drugs are significant, expert says

By Steven Reinberg
HealthDay Reporter

THURSDAY, Sept. 19 (HealthDay News) -- The statin medications that millions of adults take to lower their cholesterol levels may also raise their risk of developing cataracts, a new study suggests.

This is the latest of several studies looking for a link between statins such as Lipitor and Zocor and cataracts, a clouding of the lens of the eye. The results to date have been conflicting and inconclusive, the researchers note.

"Cataracts are a main cause of poor vision and blindness, specifically for the elderly," said lead investigator Dr. Ishak Mansi, of the VA North Texas Health System in Dallas.

"This study cannot identify that statins cause cataracts; rather, it identifies statin use as associated with a higher risk of being diagnosed with cataract," he added.

The report, published Sept. 19 in the online edition of JAMA Ophthalmology, involved almost 14,000 men and women, 6,972 pairs of statin users and nonusers, who were seen by the military health care system from October 2001 to March 2010.

Those taking statins had a 27 percent increased risk of developing cataracts compared with nonusers, the researchers found.

"We tried to slice the data in different directions and look at our findings from different angles and approaches of analyses to ensure its consistency," Mansi said. "Consistently, statin use was associated with higher risk of cataract."

The findings should encourage patients to talk with their doctor about the risks and benefits of these drugs, but they shouldn't discontinue them based on this study, Mansi added.

"These medications have been a main tool in treatment of heart disease and should not be stopped because of a small higher risk of association with other diseases," he said.

The best way to prevent heart disease, however, is to modify your lifestyle, Mansi added.

"Effective medications are expected to have side effects; it is much better to do your best to lower your own risk of cardiovascular disease by stopping smoking and keeping physically active than to take a pill to lower your risk of heart disease," he said.

One expert doesn't think this study adds to the evidence of an association between statins and cataracts.

"The fact that many such observational studies gave conflicting results -- some suggest statin use prevents cataract, while others, like this one, suggest that it might increase cataract development -- means we have no idea," said Dr. Alfred Sommer, a professor of ophthalmology at the Johns Hopkins Bloomberg School of Public Health in Baltimore.

The only definitive way to answer the question is to randomize patients to use statins and not use statins, and then see what their risk of cataract becomes, he said.

"But this would be unethical, because statins save lives," Sommer added.

Even if there is an increased risk of cataracts from statin use, which remains uncertain, people should still take statins if they are indicated, Sommer said.

"Statins reduce the risk of heart attacks, something that is frequently lethal," he said. Cataract surgery, on the other hand, is highly effective, and has only rare complications, he noted.

More information

For more information on statins, visit the U.S. National Library of Medicine.

SOURCES: Ishak Mansi, M.D., chief, Anticoagulation Section, VA North Texas Health System, Dallas; Alfred Sommer, M.D., professor, ophthalmology, and dean emeritus, Bloomberg School of Public Health, Johns Hopkins University, Baltimore; Sept. 19, 2013, JAMA Ophthalmology, online

Copyright © 2013 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=680331

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Cataract
Risk
Heart
Research Personnel
Heart Diseases
Association
Specialty Chemicals and Products
Eye
Cholesterol
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact